saracatinib [Supplementary Concept]
inhibits c-Src and Abl kinases
Date introduced: December 3, 2006
MeSH Unique ID: C515233
Registry Number: 9KD24QGH76
Heading Mapped to:
Entry Terms:
- N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine
- 4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methyl-1- piperazinyl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)-
- AZD 0530
- AZD-0530
- AZD0530
- saracatinib difumerate
- AZD0530 Difumarate
- N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-((tetrahydro- 2H-pyran-4-yl)oxy)quinazolin-4-amine bi((2E)-but-2-enedioate)
Pharmacologic Action: